nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludarabine—Cytarabine—Gemcitabine—breast cancer	0.126	0.513	CrCrCtD
Fludarabine—Azacitidine—Gemcitabine—breast cancer	0.12	0.487	CrCrCtD
Fludarabine—RRM1—Gemcitabine—breast cancer	0.107	0.231	CbGbCtD
Fludarabine—SLC28A3—Gemcitabine—breast cancer	0.0926	0.2	CbGbCtD
Fludarabine—POLA1—Gemcitabine—breast cancer	0.0926	0.2	CbGbCtD
Fludarabine—SLC29A1—Gemcitabine—breast cancer	0.0616	0.133	CbGbCtD
Fludarabine—DCK—Gemcitabine—breast cancer	0.057	0.123	CbGbCtD
Fludarabine—SLC29A1—Fluorouracil—breast cancer	0.0527	0.114	CbGbCtD
Fludarabine—SLC28A3—nipple—breast cancer	0.00274	0.0619	CbGeAlD
Fludarabine—POLA1—mammary gland—breast cancer	0.00233	0.0526	CbGeAlD
Fludarabine—RRM1—mammary gland—breast cancer	0.00185	0.0418	CbGeAlD
Fludarabine—RRM1—nipple—breast cancer	0.00153	0.0345	CbGeAlD
Fludarabine—SLC29A1—mammary gland—breast cancer	0.0015	0.034	CbGeAlD
Fludarabine—SLC28A3—adipose tissue—breast cancer	0.00149	0.0337	CbGeAlD
Fludarabine—SLC28A3—bone marrow—breast cancer	0.00129	0.0293	CbGeAlD
Fludarabine—SLC28A3—female gonad—breast cancer	0.00125	0.0282	CbGeAlD
Fludarabine—SLC29A1—nipple—breast cancer	0.00124	0.0281	CbGeAlD
Fludarabine—DCK—nipple—breast cancer	0.00119	0.0268	CbGeAlD
Fludarabine—POLA1—endometrium—breast cancer	0.00116	0.0263	CbGeAlD
Fludarabine—POLA1—pituitary gland—breast cancer	0.00105	0.0238	CbGeAlD
Fludarabine—POLA1—adipose tissue—breast cancer	0.00105	0.0237	CbGeAlD
Fludarabine—DCK—embryo—breast cancer	0.000979	0.0221	CbGeAlD
Fludarabine—RRM1—skin of body—breast cancer	0.000979	0.0221	CbGeAlD
Fludarabine—POLA1—adrenal gland—breast cancer	0.00094	0.0212	CbGeAlD
Fludarabine—RRM1—endometrium—breast cancer	0.000923	0.0209	CbGeAlD
Fludarabine—POLA1—bone marrow—breast cancer	0.000909	0.0206	CbGeAlD
Fludarabine—POLA1—female gonad—breast cancer	0.000876	0.0198	CbGeAlD
Fludarabine—RRM1—uterus—breast cancer	0.00085	0.0192	CbGeAlD
Fludarabine—RRM1—pituitary gland—breast cancer	0.000835	0.0189	CbGeAlD
Fludarabine—RRM1—adipose tissue—breast cancer	0.000832	0.0188	CbGeAlD
Fludarabine—RRM1—female reproductive system—breast cancer	0.000764	0.0173	CbGeAlD
Fludarabine—SLC29A1—endometrium—breast cancer	0.00075	0.017	CbGeAlD
Fludarabine—RRM1—adrenal gland—breast cancer	0.000746	0.0169	CbGeAlD
Fludarabine—RRM1—bone marrow—breast cancer	0.000722	0.0163	CbGeAlD
Fludarabine—DCK—endometrium—breast cancer	0.000717	0.0162	CbGeAlD
Fludarabine—RRM1—female gonad—breast cancer	0.000696	0.0157	CbGeAlD
Fludarabine—SLC29A1—uterus—breast cancer	0.000691	0.0156	CbGeAlD
Fludarabine—SLC29A1—pituitary gland—breast cancer	0.000679	0.0153	CbGeAlD
Fludarabine—SLC29A1—adipose tissue—breast cancer	0.000676	0.0153	CbGeAlD
Fludarabine—DCK—uterus—breast cancer	0.00066	0.0149	CbGeAlD
Fludarabine—DCK—pituitary gland—breast cancer	0.000649	0.0147	CbGeAlD
Fludarabine—RRM1—endocrine gland—breast cancer	0.000647	0.0146	CbGeAlD
Fludarabine—DCK—adipose tissue—breast cancer	0.000646	0.0146	CbGeAlD
Fludarabine—SLC29A1—female reproductive system—breast cancer	0.000622	0.014	CbGeAlD
Fludarabine—SLC29A1—adrenal gland—breast cancer	0.000607	0.0137	CbGeAlD
Fludarabine—DCK—female reproductive system—breast cancer	0.000594	0.0134	CbGeAlD
Fludarabine—SLC29A1—bone marrow—breast cancer	0.000587	0.0133	CbGeAlD
Fludarabine—DCK—adrenal gland—breast cancer	0.000579	0.0131	CbGeAlD
Fludarabine—SLC29A1—female gonad—breast cancer	0.000566	0.0128	CbGeAlD
Fludarabine—POLA1—lymph node—breast cancer	0.000563	0.0127	CbGeAlD
Fludarabine—DCK—bone marrow—breast cancer	0.000561	0.0127	CbGeAlD
Fludarabine—Azacitidine—DNMT3A—breast cancer	0.000543	0.114	CrCbGaD
Fludarabine—DCK—female gonad—breast cancer	0.00054	0.0122	CbGeAlD
Fludarabine—SLC29A1—endocrine gland—breast cancer	0.000526	0.0119	CbGeAlD
Fludarabine—DCK—endocrine gland—breast cancer	0.000502	0.0114	CbGeAlD
Fludarabine—Adenosine triphosphate—ARAF—breast cancer	0.000496	0.105	CrCbGaD
Fludarabine—Azacitidine—CDA—breast cancer	0.000484	0.102	CrCbGaD
Fludarabine—DCK—Topotecan—Irinotecan—breast cancer	0.00048	0.181	CbGdCrCtD
Fludarabine—POLA1—Vinblastine—Vinorelbine—breast cancer	0.000452	0.17	CbGdCrCtD
Fludarabine—RRM1—lymph node—breast cancer	0.000447	0.0101	CbGeAlD
Fludarabine—SLC29A1—lymph node—breast cancer	0.000364	0.00822	CbGeAlD
Fludarabine—DCK—lymph node—breast cancer	0.000347	0.00785	CbGeAlD
Fludarabine—Adenosine monophosphate—PIM1—breast cancer	0.000329	0.0693	CrCbGaD
Fludarabine—Flavin adenine dinucleotide—NQO2—breast cancer	0.000307	0.0646	CrCbGaD
Fludarabine—Azacitidine—DNMT1—breast cancer	0.000293	0.0618	CrCbGaD
Fludarabine—Adenosine triphosphate—HSPA1B—breast cancer	0.000285	0.0601	CrCbGaD
Fludarabine—Adenosine monophosphate—APRT—breast cancer	0.00028	0.0589	CrCbGaD
Fludarabine—Cytarabine—CDA—breast cancer	0.000276	0.0582	CrCbGaD
Fludarabine—POLA1—Norethindrone—Fluoxymesterone—breast cancer	0.000247	0.0929	CbGdCrCtD
Fludarabine—DCK—Epirubicin—Idarubicin—breast cancer	0.000246	0.0926	CbGdCrCtD
Fludarabine—DCK—Doxorubicin—Idarubicin—breast cancer	0.000246	0.0926	CbGdCrCtD
Fludarabine—RRM1—Azacitidine—Gemcitabine—breast cancer	0.000245	0.0923	CbGdCrCtD
Fludarabine—Adenosine triphosphate—ACVR1—breast cancer	0.000242	0.0511	CrCbGaD
Fludarabine—DCK—Clomifene—Toremifene—breast cancer	0.000236	0.0887	CbGdCrCtD
Fludarabine—Flavin adenine dinucleotide—DPYD—breast cancer	0.000213	0.0448	CrCbGaD
Fludarabine—Flavin adenine dinucleotide—NQO1—breast cancer	0.00015	0.0316	CrCbGaD
Fludarabine—DCK—Clomifene—Tamoxifen—breast cancer	0.000148	0.0557	CbGdCrCtD
Fludarabine—DCK—Desoximetasone—Fluoxymesterone—breast cancer	0.000138	0.0521	CbGdCrCtD
Fludarabine—Adenosine triphosphate—ALK—breast cancer	0.000131	0.0276	CrCbGaD
Fludarabine—S-Adenosylmethionine—COMT—breast cancer	0.000118	0.025	CrCbGaD
Fludarabine—Adenosine monophosphate—PDE4D—breast cancer	0.000115	0.0243	CrCbGaD
Fludarabine—DCK—Doxorubicin—Epirubicin—breast cancer	0.000113	0.0425	CbGdCrCtD
Fludarabine—DCK—Epirubicin—Doxorubicin—breast cancer	0.000104	0.0393	CbGdCrCtD
Fludarabine—Adenosine triphosphate—AKT1—breast cancer	0.000102	0.0215	CrCbGaD
Fludarabine—Adenosine monophosphate—SRC—breast cancer	0.000101	0.0212	CrCbGaD
Fludarabine—Adenosine triphosphate—ABL1—breast cancer	9.65e-05	0.0203	CrCbGaD
Fludarabine—Clofarabine—ABCG2—breast cancer	8.78e-05	0.0185	CrCbGaD
Fludarabine—Cladribine—ABCG2—breast cancer	5.04e-05	0.0106	CrCbGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDK4—breast cancer	3.64e-05	0.000416	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	3.63e-05	0.000416	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ABCC1—breast cancer	3.62e-05	0.000414	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—HMMR—breast cancer	3.62e-05	0.000414	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GSTA3—breast cancer	3.62e-05	0.000414	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—ESR1—breast cancer	3.62e-05	0.000414	CbGpPWpGaD
Fludarabine—POLA1—G1/S Transition—CDKN1A—breast cancer	3.56e-05	0.000407	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—NCOA1—breast cancer	3.55e-05	0.000406	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—NFKBIA—breast cancer	3.53e-05	0.000404	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—breast cancer	3.53e-05	0.000404	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PPARGC1B—breast cancer	3.51e-05	0.000401	CbGpPWpGaD
Fludarabine—POLA1—S Phase—CDKN1B—breast cancer	3.5e-05	0.0004	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ANGPTL4—breast cancer	3.46e-05	0.000396	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ESRRA—breast cancer	3.46e-05	0.000396	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—PLG—breast cancer	3.46e-05	0.000395	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	3.44e-05	0.000393	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—APC—breast cancer	3.42e-05	0.000391	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGF—breast cancer	3.38e-05	0.000387	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—RAD51—breast cancer	3.36e-05	0.000384	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	3.34e-05	0.000382	CbGpPWpGaD
Fludarabine—POLA1—S Phase—CCND1—breast cancer	3.34e-05	0.000382	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	3.34e-05	0.000381	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CA9—breast cancer	3.31e-05	0.000379	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GSTA4—breast cancer	3.31e-05	0.000379	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—TOP2A—breast cancer	3.28e-05	0.000375	CbGpPWpGaD
Fludarabine—DCK—Metabolism—HADHB—breast cancer	3.28e-05	0.000375	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GPI—breast cancer	3.28e-05	0.000375	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	3.27e-05	0.000374	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDKN1B—breast cancer	3.25e-05	0.000371	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GSTA2—breast cancer	3.23e-05	0.000369	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GPX2—breast cancer	3.23e-05	0.000369	CbGpPWpGaD
Fludarabine—POLA1—S Phase—CDKN1A—breast cancer	3.23e-05	0.000369	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—SULT1A1—breast cancer	3.19e-05	0.000365	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GPX4—breast cancer	3.19e-05	0.000365	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—HMOX1—breast cancer	3.19e-05	0.000365	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP8—breast cancer	3.19e-05	0.000365	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—IGF1—breast cancer	3.13e-05	0.000358	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—AURKA—breast cancer	3.13e-05	0.000358	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ALDH7A1—breast cancer	3.13e-05	0.000358	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ALDH1A1—breast cancer	3.13e-05	0.000358	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GSTA1—breast cancer	3.12e-05	0.000356	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—IDH1—breast cancer	3.12e-05	0.000356	CbGpPWpGaD
Fludarabine—Fatigue—Paclitaxel—breast cancer	3.12e-05	0.000206	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	3.11e-05	0.000356	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—NBN—breast cancer	3.11e-05	0.000356	CbGpPWpGaD
Fludarabine—Haemorrhage—Methotrexate—breast cancer	3.11e-05	0.000206	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CCND1—breast cancer	3.1e-05	0.000354	CbGpPWpGaD
Fludarabine—Asthenia—Gemcitabine—breast cancer	3.1e-05	0.000205	CcSEcCtD
Fludarabine—Myalgia—Capecitabine—breast cancer	3.09e-05	0.000205	CcSEcCtD
Fludarabine—Arthralgia—Capecitabine—breast cancer	3.09e-05	0.000205	CcSEcCtD
Fludarabine—Pain—Paclitaxel—breast cancer	3.09e-05	0.000205	CcSEcCtD
Fludarabine—Constipation—Paclitaxel—breast cancer	3.09e-05	0.000205	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	3.09e-05	0.000353	CbGpPWpGaD
Fludarabine—Haematuria—Epirubicin—breast cancer	3.09e-05	0.000205	CcSEcCtD
Fludarabine—Confusional state—Docetaxel—breast cancer	3.09e-05	0.000205	CcSEcCtD
Fludarabine—Pharyngitis—Methotrexate—breast cancer	3.08e-05	0.000204	CcSEcCtD
Fludarabine—RRM1—Metabolism—NAT2—breast cancer	3.08e-05	0.000352	CbGpPWpGaD
Fludarabine—Anaphylactic shock—Docetaxel—breast cancer	3.06e-05	0.000203	CcSEcCtD
Fludarabine—Oedema—Docetaxel—breast cancer	3.06e-05	0.000203	CcSEcCtD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—ABCB1—breast cancer	3.06e-05	0.00035	CbGpPWpGaD
Fludarabine—Discomfort—Capecitabine—breast cancer	3.06e-05	0.000202	CcSEcCtD
Fludarabine—Epistaxis—Epirubicin—breast cancer	3.06e-05	0.000202	CcSEcCtD
Fludarabine—Pruritus—Gemcitabine—breast cancer	3.05e-05	0.000202	CcSEcCtD
Fludarabine—Nausea—Thiotepa—breast cancer	3.05e-05	0.000202	CcSEcCtD
Fludarabine—Infection—Docetaxel—breast cancer	3.04e-05	0.000202	CcSEcCtD
Fludarabine—Sinusitis—Epirubicin—breast cancer	3.04e-05	0.000201	CcSEcCtD
Fludarabine—Hyperglycaemia—Doxorubicin—breast cancer	3.03e-05	0.000201	CcSEcCtD
Fludarabine—Diarrhoea—Irinotecan—breast cancer	3.03e-05	0.000201	CcSEcCtD
Fludarabine—Diarrhoea—Mitoxantrone—breast cancer	3.03e-05	0.000201	CcSEcCtD
Fludarabine—Pneumonia—Doxorubicin—breast cancer	3.01e-05	0.0002	CcSEcCtD
Fludarabine—Nervous system disorder—Docetaxel—breast cancer	3e-05	0.000199	CcSEcCtD
Fludarabine—Pruritus—Fluorouracil—breast cancer	3e-05	0.000199	CcSEcCtD
Fludarabine—DCK—Metabolism—NME1—breast cancer	3e-05	0.000343	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ADSL—breast cancer	3e-05	0.000343	CbGpPWpGaD
Fludarabine—DCK—Metabolism—FHL2—breast cancer	3e-05	0.000343	CbGpPWpGaD
Fludarabine—DCK—Metabolism—UMPS—breast cancer	3e-05	0.000343	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PHGDH—breast cancer	3e-05	0.000343	CbGpPWpGaD
Fludarabine—Thrombocytopenia—Docetaxel—breast cancer	3e-05	0.000199	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDKN1A—breast cancer	3e-05	0.000343	CbGpPWpGaD
Fludarabine—Visual impairment—Methotrexate—breast cancer	2.99e-05	0.000198	CcSEcCtD
Fludarabine—Confusional state—Capecitabine—breast cancer	2.99e-05	0.000198	CcSEcCtD
Fludarabine—Feeling abnormal—Paclitaxel—breast cancer	2.98e-05	0.000197	CcSEcCtD
Fludarabine—Stevens-Johnson syndrome—Doxorubicin—breast cancer	2.97e-05	0.000197	CcSEcCtD
Fludarabine—Oedema—Capecitabine—breast cancer	2.97e-05	0.000196	CcSEcCtD
Fludarabine—Diarrhoea—Gemcitabine—breast cancer	2.95e-05	0.000196	CcSEcCtD
Fludarabine—POLA1—G1/S Transition—MYC—breast cancer	2.95e-05	0.000337	CbGpPWpGaD
Fludarabine—Renal failure—Doxorubicin—breast cancer	2.95e-05	0.000195	CcSEcCtD
Fludarabine—Infection—Capecitabine—breast cancer	2.95e-05	0.000195	CcSEcCtD
Fludarabine—DCK—Metabolism—LDHB—breast cancer	2.94e-05	0.000336	CbGpPWpGaD
Fludarabine—DCK—Metabolism—BRIP1—breast cancer	2.94e-05	0.000336	CbGpPWpGaD
Fludarabine—DCK—Metabolism—HPSE—breast cancer	2.94e-05	0.000336	CbGpPWpGaD
Fludarabine—Erythema multiforme—Methotrexate—breast cancer	2.94e-05	0.000195	CcSEcCtD
Fludarabine—Neuropathy peripheral—Doxorubicin—breast cancer	2.94e-05	0.000195	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—TOP2A—breast cancer	2.93e-05	0.000336	CbGpPWpGaD
Fludarabine—Haemoglobin—Epirubicin—breast cancer	2.92e-05	0.000194	CcSEcCtD
Fludarabine—Stomatitis—Doxorubicin—breast cancer	2.92e-05	0.000194	CcSEcCtD
Fludarabine—Anorexia—Docetaxel—breast cancer	2.92e-05	0.000193	CcSEcCtD
Fludarabine—Urinary tract infection—Doxorubicin—breast cancer	2.91e-05	0.000193	CcSEcCtD
Fludarabine—Nervous system disorder—Capecitabine—breast cancer	2.91e-05	0.000193	CcSEcCtD
Fludarabine—Haemorrhage—Epirubicin—breast cancer	2.91e-05	0.000193	CcSEcCtD
Fludarabine—POLA1—Mitotic M-M/G1 phases—H2AFX—breast cancer	2.91e-05	0.000332	CbGpPWpGaD
Fludarabine—Diarrhoea—Fluorouracil—breast cancer	2.9e-05	0.000192	CcSEcCtD
Fludarabine—Thrombocytopenia—Capecitabine—breast cancer	2.9e-05	0.000192	CcSEcCtD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—breast cancer	2.9e-05	0.000332	CbGpPWpGaD
Fludarabine—Hypoaesthesia—Epirubicin—breast cancer	2.89e-05	0.000192	CcSEcCtD
Fludarabine—POLA1—Mitotic M-M/G1 phases—E2F1—breast cancer	2.89e-05	0.00033	CbGpPWpGaD
Fludarabine—Pharyngitis—Epirubicin—breast cancer	2.89e-05	0.000191	CcSEcCtD
Fludarabine—Hyperhidrosis—Capecitabine—breast cancer	2.87e-05	0.00019	CcSEcCtD
Fludarabine—Haematuria—Doxorubicin—breast cancer	2.86e-05	0.000189	CcSEcCtD
Fludarabine—Body temperature increased—Paclitaxel—breast cancer	2.86e-05	0.000189	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	2.84e-05	0.000325	CbGpPWpGaD
Fludarabine—Epistaxis—Doxorubicin—breast cancer	2.83e-05	0.000187	CcSEcCtD
Fludarabine—Anorexia—Capecitabine—breast cancer	2.83e-05	0.000187	CcSEcCtD
Fludarabine—Vomiting—Irinotecan—breast cancer	2.82e-05	0.000187	CcSEcCtD
Fludarabine—Vomiting—Mitoxantrone—breast cancer	2.82e-05	0.000187	CcSEcCtD
Fludarabine—Sinusitis—Doxorubicin—breast cancer	2.81e-05	0.000186	CcSEcCtD
Fludarabine—Visual impairment—Epirubicin—breast cancer	2.8e-05	0.000186	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—AURKA—breast cancer	2.8e-05	0.00032	CbGpPWpGaD
Fludarabine—Rash—Mitoxantrone—breast cancer	2.79e-05	0.000185	CcSEcCtD
Fludarabine—Rash—Irinotecan—breast cancer	2.79e-05	0.000185	CcSEcCtD
Fludarabine—Dermatitis—Irinotecan—breast cancer	2.79e-05	0.000185	CcSEcCtD
Fludarabine—Dermatitis—Mitoxantrone—breast cancer	2.79e-05	0.000185	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Docetaxel—breast cancer	2.79e-05	0.000185	CcSEcCtD
Fludarabine—DCK—Metabolism—HMMR—breast cancer	2.79e-05	0.000319	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ABCC1—breast cancer	2.79e-05	0.000319	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GSTA3—breast cancer	2.79e-05	0.000319	CbGpPWpGaD
Fludarabine—Chills—Methotrexate—breast cancer	2.79e-05	0.000185	CcSEcCtD
Fludarabine—Headache—Mitoxantrone—breast cancer	2.78e-05	0.000184	CcSEcCtD
Fludarabine—Headache—Irinotecan—breast cancer	2.78e-05	0.000184	CcSEcCtD
Fludarabine—Paraesthesia—Docetaxel—breast cancer	2.75e-05	0.000182	CcSEcCtD
Fludarabine—Erythema multiforme—Epirubicin—breast cancer	2.75e-05	0.000182	CcSEcCtD
Fludarabine—Alopecia—Methotrexate—breast cancer	2.75e-05	0.000182	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	2.75e-05	0.000314	CbGpPWpGaD
Fludarabine—Vomiting—Gemcitabine—breast cancer	2.74e-05	0.000182	CcSEcCtD
Fludarabine—Cytarabine—CYP3A4—breast cancer	2.74e-05	0.00577	CrCbGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—HSP90AA1—breast cancer	2.74e-05	0.000313	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—BCL2—breast cancer	2.74e-05	0.000313	CbGpPWpGaD
Fludarabine—Dyspnoea—Docetaxel—breast cancer	2.73e-05	0.000181	CcSEcCtD
Fludarabine—Rash—Gemcitabine—breast cancer	2.72e-05	0.00018	CcSEcCtD
Fludarabine—Dermatitis—Gemcitabine—breast cancer	2.72e-05	0.00018	CcSEcCtD
Fludarabine—POLA1—Mitotic M-M/G1 phases—BIRC5—breast cancer	2.71e-05	0.00031	CbGpPWpGaD
Fludarabine—Malnutrition—Methotrexate—breast cancer	2.7e-05	0.000179	CcSEcCtD
Fludarabine—Haemoglobin—Doxorubicin—breast cancer	2.7e-05	0.000179	CcSEcCtD
Fludarabine—Headache—Gemcitabine—breast cancer	2.7e-05	0.000179	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Capecitabine—breast cancer	2.7e-05	0.000179	CcSEcCtD
Fludarabine—RRM1—Metabolism—DPYD—breast cancer	2.7e-05	0.000309	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—MED12—breast cancer	2.7e-05	0.000309	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PPARGC1B—breast cancer	2.7e-05	0.000309	CbGpPWpGaD
Fludarabine—Vomiting—Fluorouracil—breast cancer	2.7e-05	0.000179	CcSEcCtD
Fludarabine—Dyspepsia—Docetaxel—breast cancer	2.7e-05	0.000179	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MDM2—breast cancer	2.7e-05	0.000308	CbGpPWpGaD
Fludarabine—Haemorrhage—Doxorubicin—breast cancer	2.69e-05	0.000178	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—RAF1—breast cancer	2.69e-05	0.000307	CbGpPWpGaD
Fludarabine—POLA1—S Phase—MYC—breast cancer	2.68e-05	0.000306	CbGpPWpGaD
Fludarabine—Hypoaesthesia—Doxorubicin—breast cancer	2.68e-05	0.000177	CcSEcCtD
Fludarabine—Rash—Fluorouracil—breast cancer	2.68e-05	0.000177	CcSEcCtD
Fludarabine—Dermatitis—Fluorouracil—breast cancer	2.67e-05	0.000177	CcSEcCtD
Fludarabine—Pharyngitis—Doxorubicin—breast cancer	2.67e-05	0.000177	CcSEcCtD
Fludarabine—Paraesthesia—Capecitabine—breast cancer	2.66e-05	0.000176	CcSEcCtD
Fludarabine—Decreased appetite—Docetaxel—breast cancer	2.66e-05	0.000176	CcSEcCtD
Fludarabine—Hypersensitivity—Paclitaxel—breast cancer	2.66e-05	0.000176	CcSEcCtD
Fludarabine—RRM1—Metabolism—ALDOA—breast cancer	2.66e-05	0.000304	CbGpPWpGaD
Fludarabine—Headache—Fluorouracil—breast cancer	2.66e-05	0.000176	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—breast cancer	2.66e-05	0.000304	CbGpPWpGaD
Fludarabine—Gastrointestinal disorder—Docetaxel—breast cancer	2.64e-05	0.000175	CcSEcCtD
Fludarabine—Dyspnoea—Capecitabine—breast cancer	2.64e-05	0.000175	CcSEcCtD
Fludarabine—Fatigue—Docetaxel—breast cancer	2.64e-05	0.000175	CcSEcCtD
Fludarabine—Nausea—Irinotecan—breast cancer	2.63e-05	0.000174	CcSEcCtD
Fludarabine—Nausea—Mitoxantrone—breast cancer	2.63e-05	0.000174	CcSEcCtD
Fludarabine—Constipation—Docetaxel—breast cancer	2.62e-05	0.000173	CcSEcCtD
Fludarabine—Pain—Docetaxel—breast cancer	2.62e-05	0.000173	CcSEcCtD
Fludarabine—Dyspepsia—Capecitabine—breast cancer	2.61e-05	0.000173	CcSEcCtD
Fludarabine—Chills—Epirubicin—breast cancer	2.61e-05	0.000173	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—breast cancer	2.6e-05	0.000297	CbGpPWpGaD
Fludarabine—Arrhythmia—Epirubicin—breast cancer	2.6e-05	0.000172	CcSEcCtD
Fludarabine—Visual impairment—Doxorubicin—breast cancer	2.59e-05	0.000172	CcSEcCtD
Fludarabine—Asthenia—Paclitaxel—breast cancer	2.59e-05	0.000172	CcSEcCtD
Fludarabine—RRM1—Metabolism—NCOA3—breast cancer	2.58e-05	0.000295	CbGpPWpGaD
Fludarabine—Decreased appetite—Capecitabine—breast cancer	2.58e-05	0.000171	CcSEcCtD
Fludarabine—Alopecia—Epirubicin—breast cancer	2.57e-05	0.00017	CcSEcCtD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—ALB—breast cancer	2.57e-05	0.000294	CbGpPWpGaD
Fludarabine—Nausea—Gemcitabine—breast cancer	2.56e-05	0.00017	CcSEcCtD
Fludarabine—RRM1—Metabolism—SLC2A2—breast cancer	2.56e-05	0.000293	CbGpPWpGaD
Fludarabine—Gastrointestinal disorder—Capecitabine—breast cancer	2.56e-05	0.00017	CcSEcCtD
Fludarabine—Fatigue—Capecitabine—breast cancer	2.56e-05	0.000169	CcSEcCtD
Fludarabine—Pruritus—Paclitaxel—breast cancer	2.56e-05	0.000169	CcSEcCtD
Fludarabine—DCK—Metabolism—CA9—breast cancer	2.55e-05	0.000292	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GSTA4—breast cancer	2.55e-05	0.000292	CbGpPWpGaD
Fludarabine—Erythema multiforme—Doxorubicin—breast cancer	2.54e-05	0.000169	CcSEcCtD
Fludarabine—Constipation—Capecitabine—breast cancer	2.54e-05	0.000168	CcSEcCtD
Fludarabine—Pain—Capecitabine—breast cancer	2.54e-05	0.000168	CcSEcCtD
Fludarabine—Malnutrition—Epirubicin—breast cancer	2.53e-05	0.000168	CcSEcCtD
Fludarabine—Feeling abnormal—Docetaxel—breast cancer	2.52e-05	0.000167	CcSEcCtD
Fludarabine—Nausea—Fluorouracil—breast cancer	2.52e-05	0.000167	CcSEcCtD
Fludarabine—RRM1—Metabolism—MTR—breast cancer	2.51e-05	0.000287	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CPT1A—breast cancer	2.51e-05	0.000287	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ABCG2—breast cancer	2.51e-05	0.000287	CbGpPWpGaD
Fludarabine—Ill-defined disorder—Methotrexate—breast cancer	2.51e-05	0.000166	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—CHEK2—breast cancer	2.5e-05	0.000286	CbGpPWpGaD
Fludarabine—Anaemia—Methotrexate—breast cancer	2.5e-05	0.000166	CcSEcCtD
Fludarabine—POLA1—Mitotic M-M/G1 phases—CDK2—breast cancer	2.49e-05	0.000285	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—MYC—breast cancer	2.49e-05	0.000284	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GSTA2—breast cancer	2.49e-05	0.000284	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GPX2—breast cancer	2.49e-05	0.000284	CbGpPWpGaD
Fludarabine—Diarrhoea—Paclitaxel—breast cancer	2.47e-05	0.000164	CcSEcCtD
Fludarabine—RRM1—Metabolism—HPGDS—breast cancer	2.46e-05	0.000282	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—breast cancer	2.46e-05	0.000281	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GPX4—breast cancer	2.45e-05	0.000281	CbGpPWpGaD
Fludarabine—DCK—Metabolism—SULT1A1—breast cancer	2.45e-05	0.000281	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—HBA1—breast cancer	2.45e-05	0.00028	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—HSP90AA1—breast cancer	2.45e-05	0.00028	CbGpPWpGaD
Fludarabine—Feeling abnormal—Capecitabine—breast cancer	2.44e-05	0.000162	CcSEcCtD
Fludarabine—Malaise—Methotrexate—breast cancer	2.44e-05	0.000162	CcSEcCtD
Fludarabine—Body temperature increased—Docetaxel—breast cancer	2.42e-05	0.00016	CcSEcCtD
Fludarabine—Leukopenia—Methotrexate—breast cancer	2.42e-05	0.00016	CcSEcCtD
Fludarabine—Chills—Doxorubicin—breast cancer	2.41e-05	0.00016	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—breast cancer	2.41e-05	0.000276	CbGpPWpGaD
Fludarabine—Arrhythmia—Doxorubicin—breast cancer	2.4e-05	0.000159	CcSEcCtD
Fludarabine—DCK—Metabolism—IDH1—breast cancer	2.4e-05	0.000274	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GSTA1—breast cancer	2.4e-05	0.000274	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ACHE—breast cancer	2.39e-05	0.000273	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GSTT1—breast cancer	2.39e-05	0.000273	CbGpPWpGaD
Fludarabine—Alopecia—Doxorubicin—breast cancer	2.38e-05	0.000157	CcSEcCtD
Fludarabine—DCK—Metabolism—NAT2—breast cancer	2.37e-05	0.000271	CbGpPWpGaD
Fludarabine—Cough—Methotrexate—breast cancer	2.36e-05	0.000156	CcSEcCtD
Fludarabine—Ill-defined disorder—Epirubicin—breast cancer	2.35e-05	0.000156	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—breast cancer	2.35e-05	0.000268	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—BRCA1—breast cancer	2.35e-05	0.000268	CbGpPWpGaD
Fludarabine—Body temperature increased—Capecitabine—breast cancer	2.34e-05	0.000155	CcSEcCtD
Fludarabine—Convulsion—Methotrexate—breast cancer	2.34e-05	0.000155	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—JUN—breast cancer	2.34e-05	0.000268	CbGpPWpGaD
Fludarabine—Malnutrition—Doxorubicin—breast cancer	2.34e-05	0.000155	CcSEcCtD
Fludarabine—Anaemia—Epirubicin—breast cancer	2.34e-05	0.000155	CcSEcCtD
Fludarabine—Agitation—Epirubicin—breast cancer	2.33e-05	0.000154	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—breast cancer	2.32e-05	0.000266	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—RAF1—breast cancer	2.32e-05	0.000266	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	2.32e-05	0.000265	CbGpPWpGaD
Fludarabine—Arthralgia—Methotrexate—breast cancer	2.3e-05	0.000153	CcSEcCtD
Fludarabine—Myalgia—Methotrexate—breast cancer	2.3e-05	0.000153	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—CCNE1—breast cancer	2.3e-05	0.000263	CbGpPWpGaD
Fludarabine—Vomiting—Paclitaxel—breast cancer	2.3e-05	0.000152	CcSEcCtD
Fludarabine—Malaise—Epirubicin—breast cancer	2.28e-05	0.000151	CcSEcCtD
Fludarabine—Rash—Paclitaxel—breast cancer	2.28e-05	0.000151	CcSEcCtD
Fludarabine—Dermatitis—Paclitaxel—breast cancer	2.28e-05	0.000151	CcSEcCtD
Fludarabine—Discomfort—Methotrexate—breast cancer	2.28e-05	0.000151	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1A—breast cancer	2.27e-05	0.00026	CbGpPWpGaD
Fludarabine—Leukopenia—Epirubicin—breast cancer	2.27e-05	0.00015	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—breast cancer	2.27e-05	0.000259	CbGpPWpGaD
Fludarabine—Headache—Paclitaxel—breast cancer	2.26e-05	0.00015	CcSEcCtD
Fludarabine—RRM1—Metabolism—CYP17A1—breast cancer	2.26e-05	0.000259	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—TYMS—breast cancer	2.26e-05	0.000258	CbGpPWpGaD
Fludarabine—Hypersensitivity—Docetaxel—breast cancer	2.26e-05	0.000149	CcSEcCtD
Fludarabine—RRM1—Metabolism—PTGS1—breast cancer	2.24e-05	0.000256	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ENO1—breast cancer	2.24e-05	0.000256	CbGpPWpGaD
Fludarabine—Confusional state—Methotrexate—breast cancer	2.23e-05	0.000147	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK8—breast cancer	2.22e-05	0.000254	CbGpPWpGaD
Fludarabine—Cough—Epirubicin—breast cancer	2.21e-05	0.000146	CcSEcCtD
Fludarabine—Anaphylactic shock—Methotrexate—breast cancer	2.21e-05	0.000146	CcSEcCtD
Fludarabine—Asthenia—Docetaxel—breast cancer	2.2e-05	0.000146	CcSEcCtD
Fludarabine—RRM1—Metabolism—CYP2D6—breast cancer	2.2e-05	0.000251	CbGpPWpGaD
Fludarabine—Convulsion—Epirubicin—breast cancer	2.19e-05	0.000145	CcSEcCtD
Fludarabine—Infection—Methotrexate—breast cancer	2.19e-05	0.000145	CcSEcCtD
Fludarabine—Hypersensitivity—Capecitabine—breast cancer	2.18e-05	0.000145	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—H2AFX—breast cancer	2.17e-05	0.000249	CbGpPWpGaD
Fludarabine—Ill-defined disorder—Doxorubicin—breast cancer	2.17e-05	0.000144	CcSEcCtD
Fludarabine—Pruritus—Docetaxel—breast cancer	2.17e-05	0.000144	CcSEcCtD
Fludarabine—Nervous system disorder—Methotrexate—breast cancer	2.16e-05	0.000143	CcSEcCtD
Fludarabine—Anaemia—Doxorubicin—breast cancer	2.16e-05	0.000143	CcSEcCtD
Fludarabine—Thrombocytopenia—Methotrexate—breast cancer	2.16e-05	0.000143	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—E2F1—breast cancer	2.16e-05	0.000247	CbGpPWpGaD
Fludarabine—Myalgia—Epirubicin—breast cancer	2.16e-05	0.000143	CcSEcCtD
Fludarabine—Arthralgia—Epirubicin—breast cancer	2.16e-05	0.000143	CcSEcCtD
Fludarabine—RRM1—Metabolism—NCOA2—breast cancer	2.15e-05	0.000246	CbGpPWpGaD
Fludarabine—Agitation—Doxorubicin—breast cancer	2.15e-05	0.000143	CcSEcCtD
Fludarabine—Nausea—Paclitaxel—breast cancer	2.15e-05	0.000142	CcSEcCtD
Fludarabine—Hyperhidrosis—Methotrexate—breast cancer	2.13e-05	0.000141	CcSEcCtD
Fludarabine—Discomfort—Epirubicin—breast cancer	2.13e-05	0.000141	CcSEcCtD
Fludarabine—Asthenia—Capecitabine—breast cancer	2.13e-05	0.000141	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—BRCA2—breast cancer	2.12e-05	0.000243	CbGpPWpGaD
Fludarabine—Malaise—Doxorubicin—breast cancer	2.11e-05	0.00014	CcSEcCtD
Fludarabine—Anorexia—Methotrexate—breast cancer	2.1e-05	0.000139	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	2.1e-05	0.00024	CbGpPWpGaD
Fludarabine—Pruritus—Capecitabine—breast cancer	2.1e-05	0.000139	CcSEcCtD
Fludarabine—Leukopenia—Doxorubicin—breast cancer	2.1e-05	0.000139	CcSEcCtD
Fludarabine—Diarrhoea—Docetaxel—breast cancer	2.1e-05	0.000139	CcSEcCtD
Fludarabine—RRM1—Metabolism—FASN—breast cancer	2.09e-05	0.000239	CbGpPWpGaD
Fludarabine—Confusional state—Epirubicin—breast cancer	2.08e-05	0.000138	CcSEcCtD
Fludarabine—RRM1—Metabolism—BCHE—breast cancer	2.08e-05	0.000238	CbGpPWpGaD
Fludarabine—DCK—Metabolism—DPYD—breast cancer	2.08e-05	0.000238	CbGpPWpGaD
Fludarabine—DCK—Metabolism—MED12—breast cancer	2.08e-05	0.000238	CbGpPWpGaD
Fludarabine—Anaphylactic shock—Epirubicin—breast cancer	2.07e-05	0.000137	CcSEcCtD
Fludarabine—Oedema—Epirubicin—breast cancer	2.07e-05	0.000137	CcSEcCtD
Fludarabine—RRM1—Metabolism—SLC5A5—breast cancer	2.06e-05	0.000235	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CCNE1—breast cancer	2.05e-05	0.000235	CbGpPWpGaD
Fludarabine—Infection—Epirubicin—breast cancer	2.05e-05	0.000136	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	2.05e-05	0.000234	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ALDOA—breast cancer	2.05e-05	0.000234	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—RB1—breast cancer	2.05e-05	0.000234	CbGpPWpGaD
Fludarabine—Cough—Doxorubicin—breast cancer	2.04e-05	0.000135	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—BIRC5—breast cancer	2.03e-05	0.000232	CbGpPWpGaD
Fludarabine—Convulsion—Doxorubicin—breast cancer	2.03e-05	0.000134	CcSEcCtD
Fludarabine—Diarrhoea—Capecitabine—breast cancer	2.03e-05	0.000134	CcSEcCtD
Fludarabine—Nervous system disorder—Epirubicin—breast cancer	2.03e-05	0.000134	CcSEcCtD
Fludarabine—Thrombocytopenia—Epirubicin—breast cancer	2.02e-05	0.000134	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—TYMS—breast cancer	2.02e-05	0.000231	CbGpPWpGaD
Fludarabine—Musculoskeletal discomfort—Methotrexate—breast cancer	2.01e-05	0.000133	CcSEcCtD
Fludarabine—Hyperhidrosis—Epirubicin—breast cancer	2e-05	0.000132	CcSEcCtD
Fludarabine—Arthralgia—Doxorubicin—breast cancer	1.99e-05	0.000132	CcSEcCtD
Fludarabine—Myalgia—Doxorubicin—breast cancer	1.99e-05	0.000132	CcSEcCtD
Fludarabine—DCK—Metabolism—NCOA3—breast cancer	1.99e-05	0.000227	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—NQO1—breast cancer	1.99e-05	0.000227	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—SLC2A1—breast cancer	1.99e-05	0.000227	CbGpPWpGaD
Fludarabine—Paraesthesia—Methotrexate—breast cancer	1.98e-05	0.000131	CcSEcCtD
Fludarabine—DCK—Metabolism—SLC2A2—breast cancer	1.97e-05	0.000226	CbGpPWpGaD
Fludarabine—Discomfort—Doxorubicin—breast cancer	1.97e-05	0.000131	CcSEcCtD
Fludarabine—Anorexia—Epirubicin—breast cancer	1.97e-05	0.00013	CcSEcCtD
Fludarabine—Dyspnoea—Methotrexate—breast cancer	1.97e-05	0.00013	CcSEcCtD
Fludarabine—Vomiting—Docetaxel—breast cancer	1.95e-05	0.000129	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—H2AFX—breast cancer	1.94e-05	0.000222	CbGpPWpGaD
Fludarabine—Dyspepsia—Methotrexate—breast cancer	1.94e-05	0.000129	CcSEcCtD
Fludarabine—RRM1—Metabolism—CYP3A4—breast cancer	1.94e-05	0.000221	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	1.94e-05	0.000221	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CPT1A—breast cancer	1.93e-05	0.000221	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ABCG2—breast cancer	1.93e-05	0.000221	CbGpPWpGaD
Fludarabine—DCK—Metabolism—MTR—breast cancer	1.93e-05	0.000221	CbGpPWpGaD
Fludarabine—Rash—Docetaxel—breast cancer	1.93e-05	0.000128	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—E2F1—breast cancer	1.93e-05	0.000221	CbGpPWpGaD
Fludarabine—Dermatitis—Docetaxel—breast cancer	1.93e-05	0.000128	CcSEcCtD
Fludarabine—Confusional state—Doxorubicin—breast cancer	1.93e-05	0.000128	CcSEcCtD
Fludarabine—Decreased appetite—Methotrexate—breast cancer	1.92e-05	0.000127	CcSEcCtD
Fludarabine—Headache—Docetaxel—breast cancer	1.92e-05	0.000127	CcSEcCtD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—ALB—breast cancer	1.91e-05	0.000219	CbGpPWpGaD
Fludarabine—Anaphylactic shock—Doxorubicin—breast cancer	1.91e-05	0.000127	CcSEcCtD
Fludarabine—Oedema—Doxorubicin—breast cancer	1.91e-05	0.000127	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Methotrexate—breast cancer	1.91e-05	0.000126	CcSEcCtD
Fludarabine—RRM1—Metabolism—CYP1B1—breast cancer	1.9e-05	0.000218	CbGpPWpGaD
Fludarabine—Fatigue—Methotrexate—breast cancer	1.9e-05	0.000126	CcSEcCtD
Fludarabine—Infection—Doxorubicin—breast cancer	1.9e-05	0.000126	CcSEcCtD
Fludarabine—DCK—Metabolism—HPGDS—breast cancer	1.9e-05	0.000217	CbGpPWpGaD
Fludarabine—Pain—Methotrexate—breast cancer	1.89e-05	0.000125	CcSEcCtD
Fludarabine—Vomiting—Capecitabine—breast cancer	1.89e-05	0.000125	CcSEcCtD
Fludarabine—DCK—Metabolism—HBA1—breast cancer	1.88e-05	0.000215	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	1.88e-05	0.000215	CbGpPWpGaD
Fludarabine—Musculoskeletal discomfort—Epirubicin—breast cancer	1.88e-05	0.000125	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	1.88e-05	0.000215	CbGpPWpGaD
Fludarabine—Nervous system disorder—Doxorubicin—breast cancer	1.87e-05	0.000124	CcSEcCtD
Fludarabine—Thrombocytopenia—Doxorubicin—breast cancer	1.87e-05	0.000124	CcSEcCtD
Fludarabine—Rash—Capecitabine—breast cancer	1.87e-05	0.000124	CcSEcCtD
Fludarabine—Dermatitis—Capecitabine—breast cancer	1.87e-05	0.000124	CcSEcCtD
Fludarabine—RRM1—Metabolism—HSP90AA1—breast cancer	1.87e-05	0.000213	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDK2—breast cancer	1.86e-05	0.000213	CbGpPWpGaD
Fludarabine—Headache—Capecitabine—breast cancer	1.86e-05	0.000123	CcSEcCtD
Fludarabine—Paraesthesia—Epirubicin—breast cancer	1.86e-05	0.000123	CcSEcCtD
Fludarabine—Hyperhidrosis—Doxorubicin—breast cancer	1.85e-05	0.000122	CcSEcCtD
Fludarabine—Dyspnoea—Epirubicin—breast cancer	1.84e-05	0.000122	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	1.84e-05	0.000211	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GSTT1—breast cancer	1.84e-05	0.00021	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ACHE—breast cancer	1.84e-05	0.00021	CbGpPWpGaD
Fludarabine—Anorexia—Doxorubicin—breast cancer	1.82e-05	0.000121	CcSEcCtD
Fludarabine—Nausea—Docetaxel—breast cancer	1.82e-05	0.000121	CcSEcCtD
Fludarabine—Feeling abnormal—Methotrexate—breast cancer	1.82e-05	0.000121	CcSEcCtD
Fludarabine—Dyspepsia—Epirubicin—breast cancer	1.82e-05	0.00012	CcSEcCtD
Fludarabine—RRM1—Metabolism—NCOA1—breast cancer	1.82e-05	0.000208	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—BIRC5—breast cancer	1.81e-05	0.000208	CbGpPWpGaD
Fludarabine—Decreased appetite—Epirubicin—breast cancer	1.8e-05	0.000119	CcSEcCtD
Fludarabine—RRM1—Metabolism—STK11—breast cancer	1.79e-05	0.000205	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CYP19A1—breast cancer	1.79e-05	0.000205	CbGpPWpGaD
Fludarabine—Adenosine triphosphate—ABCB1—breast cancer	1.78e-05	0.00376	CrCbGaD
Fludarabine—Gastrointestinal disorder—Epirubicin—breast cancer	1.78e-05	0.000118	CcSEcCtD
Fludarabine—Fatigue—Epirubicin—breast cancer	1.78e-05	0.000118	CcSEcCtD
Fludarabine—Constipation—Epirubicin—breast cancer	1.77e-05	0.000117	CcSEcCtD
Fludarabine—Pain—Epirubicin—breast cancer	1.77e-05	0.000117	CcSEcCtD
Fludarabine—Nausea—Capecitabine—breast cancer	1.76e-05	0.000117	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDK4—breast cancer	1.76e-05	0.000201	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—TERT—breast cancer	1.76e-05	0.000201	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	1.75e-05	0.000201	CbGpPWpGaD
Fludarabine—Body temperature increased—Methotrexate—breast cancer	1.75e-05	0.000116	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.74e-05	0.000115	CcSEcCtD
Fludarabine—DCK—Metabolism—CYP17A1—breast cancer	1.74e-05	0.000199	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	1.74e-05	0.000199	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—RAF1—breast cancer	1.73e-05	0.000198	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ENO1—breast cancer	1.72e-05	0.000197	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PTGS1—breast cancer	1.72e-05	0.000197	CbGpPWpGaD
Fludarabine—Paraesthesia—Doxorubicin—breast cancer	1.72e-05	0.000114	CcSEcCtD
Fludarabine—Dyspnoea—Doxorubicin—breast cancer	1.7e-05	0.000113	CcSEcCtD
Fludarabine—Feeling abnormal—Epirubicin—breast cancer	1.7e-05	0.000113	CcSEcCtD
Fludarabine—DCK—Metabolism—CYP2D6—breast cancer	1.69e-05	0.000193	CbGpPWpGaD
Fludarabine—Dyspepsia—Doxorubicin—breast cancer	1.68e-05	0.000111	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—CDK2—breast cancer	1.66e-05	0.00019	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—COMT—breast cancer	1.66e-05	0.00019	CbGpPWpGaD
Fludarabine—Decreased appetite—Doxorubicin—breast cancer	1.66e-05	0.00011	CcSEcCtD
Fludarabine—DCK—Metabolism—NCOA2—breast cancer	1.66e-05	0.00019	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GSTP1—breast cancer	1.66e-05	0.000189	CbGpPWpGaD
Fludarabine—Gastrointestinal disorder—Doxorubicin—breast cancer	1.65e-05	0.000109	CcSEcCtD
Fludarabine—Fatigue—Doxorubicin—breast cancer	1.65e-05	0.000109	CcSEcCtD
Fludarabine—Constipation—Doxorubicin—breast cancer	1.63e-05	0.000108	CcSEcCtD
Fludarabine—Pain—Doxorubicin—breast cancer	1.63e-05	0.000108	CcSEcCtD
Fludarabine—Body temperature increased—Epirubicin—breast cancer	1.63e-05	0.000108	CcSEcCtD
Fludarabine—RRM1—Metabolism—HMOX1—breast cancer	1.63e-05	0.000187	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ITPR1—breast cancer	1.63e-05	0.000186	CbGpPWpGaD
Fludarabine—Hypersensitivity—Methotrexate—breast cancer	1.63e-05	0.000108	CcSEcCtD
Fludarabine—DCK—Metabolism—FASN—breast cancer	1.61e-05	0.000184	CbGpPWpGaD
Fludarabine—DCK—Metabolism—BCHE—breast cancer	1.6e-05	0.000183	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	1.6e-05	0.000183	CbGpPWpGaD
Fludarabine—Asthenia—Methotrexate—breast cancer	1.58e-05	0.000105	CcSEcCtD
Fludarabine—DCK—Metabolism—SLC5A5—breast cancer	1.58e-05	0.000181	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—ATM—breast cancer	1.58e-05	0.000181	CbGpPWpGaD
Fludarabine—Feeling abnormal—Doxorubicin—breast cancer	1.58e-05	0.000104	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—CDK4—breast cancer	1.57e-05	0.00018	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ABCB1—breast cancer	1.57e-05	0.000179	CbGpPWpGaD
Fludarabine—Pruritus—Methotrexate—breast cancer	1.56e-05	0.000103	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	1.55e-05	0.000177	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—TYMS—breast cancer	1.54e-05	0.000176	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—RB1—breast cancer	1.53e-05	0.000175	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NQO1—breast cancer	1.53e-05	0.000175	CbGpPWpGaD
Fludarabine—DCK—Metabolism—SLC2A1—breast cancer	1.53e-05	0.000175	CbGpPWpGaD
Fludarabine—Hypersensitivity—Epirubicin—breast cancer	1.52e-05	0.000101	CcSEcCtD
Fludarabine—RRM1—Metabolism—GSTM1—breast cancer	1.52e-05	0.000174	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—NCOR1—breast cancer	1.52e-05	0.000174	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PLA2G4A—breast cancer	1.52e-05	0.000174	CbGpPWpGaD
Fludarabine—Body temperature increased—Doxorubicin—breast cancer	1.51e-05	0.0001	CcSEcCtD
Fludarabine—Diarrhoea—Methotrexate—breast cancer	1.51e-05	0.0001	CcSEcCtD
Fludarabine—DCK—Metabolism—CYP3A4—breast cancer	1.49e-05	0.00017	CbGpPWpGaD
Fludarabine—Asthenia—Epirubicin—breast cancer	1.48e-05	9.82e-05	CcSEcCtD
Fludarabine—DCK—Metabolism—CYP1B1—breast cancer	1.46e-05	0.000168	CbGpPWpGaD
Fludarabine—Pruritus—Epirubicin—breast cancer	1.46e-05	9.68e-05	CcSEcCtD
Fludarabine—RRM1—Metabolism—GPX1—breast cancer	1.46e-05	0.000167	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CYP1A1—breast cancer	1.44e-05	0.000165	CbGpPWpGaD
Fludarabine—DCK—Metabolism—HSP90AA1—breast cancer	1.44e-05	0.000164	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ERCC2—breast cancer	1.43e-05	0.000164	CbGpPWpGaD
Fludarabine—Diarrhoea—Epirubicin—breast cancer	1.41e-05	9.36e-05	CcSEcCtD
Fludarabine—Hypersensitivity—Doxorubicin—breast cancer	1.41e-05	9.33e-05	CcSEcCtD
Fludarabine—Vomiting—Methotrexate—breast cancer	1.4e-05	9.3e-05	CcSEcCtD
Fludarabine—DCK—Metabolism—NCOA1—breast cancer	1.4e-05	0.00016	CbGpPWpGaD
Fludarabine—Rash—Methotrexate—breast cancer	1.39e-05	9.22e-05	CcSEcCtD
Fludarabine—Dermatitis—Methotrexate—breast cancer	1.39e-05	9.21e-05	CcSEcCtD
Fludarabine—Headache—Methotrexate—breast cancer	1.38e-05	9.16e-05	CcSEcCtD
Fludarabine—DCK—Metabolism—STK11—breast cancer	1.38e-05	0.000157	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CYP19A1—breast cancer	1.38e-05	0.000157	CbGpPWpGaD
Fludarabine—Asthenia—Doxorubicin—breast cancer	1.37e-05	9.08e-05	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—RB1—breast cancer	1.37e-05	0.000156	CbGpPWpGaD
Fludarabine—Pruritus—Doxorubicin—breast cancer	1.35e-05	8.96e-05	CcSEcCtD
Fludarabine—RRM1—Metabolism—MTHFR—breast cancer	1.34e-05	0.000154	CbGpPWpGaD
Fludarabine—Vomiting—Epirubicin—breast cancer	1.31e-05	8.7e-05	CcSEcCtD
Fludarabine—Nausea—Methotrexate—breast cancer	1.31e-05	8.69e-05	CcSEcCtD
Fludarabine—Diarrhoea—Doxorubicin—breast cancer	1.31e-05	8.66e-05	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	1.31e-05	0.000149	CbGpPWpGaD
Fludarabine—Rash—Epirubicin—breast cancer	1.3e-05	8.63e-05	CcSEcCtD
Fludarabine—Dermatitis—Epirubicin—breast cancer	1.3e-05	8.62e-05	CcSEcCtD
Fludarabine—Headache—Epirubicin—breast cancer	1.29e-05	8.57e-05	CcSEcCtD
Fludarabine—DCK—Metabolism—COMT—breast cancer	1.28e-05	0.000146	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GSTP1—breast cancer	1.27e-05	0.000146	CbGpPWpGaD
Fludarabine—DCK—Metabolism—HMOX1—breast cancer	1.26e-05	0.000144	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ITPR1—breast cancer	1.25e-05	0.000143	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—MAPK3—breast cancer	1.25e-05	0.000143	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CAV1—breast cancer	1.24e-05	0.000142	CbGpPWpGaD
Fludarabine—Nausea—Epirubicin—breast cancer	1.23e-05	8.13e-05	CcSEcCtD
Fludarabine—Vomiting—Doxorubicin—breast cancer	1.22e-05	8.05e-05	CcSEcCtD
Fludarabine—DCK—Metabolism—ABCB1—breast cancer	1.21e-05	0.000138	CbGpPWpGaD
Fludarabine—Rash—Doxorubicin—breast cancer	1.21e-05	7.98e-05	CcSEcCtD
Fludarabine—Dermatitis—Doxorubicin—breast cancer	1.2e-05	7.98e-05	CcSEcCtD
Fludarabine—Headache—Doxorubicin—breast cancer	1.2e-05	7.93e-05	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDKN1B—breast cancer	1.19e-05	0.000136	CbGpPWpGaD
Fludarabine—DCK—Metabolism—TYMS—breast cancer	1.18e-05	0.000135	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NCOR1—breast cancer	1.17e-05	0.000134	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GSTM1—breast cancer	1.17e-05	0.000134	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PLA2G4A—breast cancer	1.17e-05	0.000134	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—MDM2—breast cancer	1.17e-05	0.000133	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CCND1—breast cancer	1.14e-05	0.00013	CbGpPWpGaD
Fludarabine—Nausea—Doxorubicin—breast cancer	1.14e-05	7.52e-05	CcSEcCtD
Fludarabine—RRM1—Metabolism—PIK3CG—breast cancer	1.13e-05	0.000129	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GPX1—breast cancer	1.12e-05	0.000128	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CYP1A1—breast cancer	1.11e-05	0.000127	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ERCC2—breast cancer	1.1e-05	0.000126	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDKN1A—breast cancer	1.1e-05	0.000126	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDKN1B—breast cancer	1.07e-05	0.000122	CbGpPWpGaD
Fludarabine—DCK—Metabolism—MTHFR—breast cancer	1.03e-05	0.000118	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CCND1—breast cancer	1.02e-05	0.000116	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PIK3CD—breast cancer	9.93e-06	0.000114	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDKN1A—breast cancer	9.83e-06	0.000112	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ALB—breast cancer	9.81e-06	0.000112	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CAV1—breast cancer	9.55e-06	0.000109	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—NOS3—breast cancer	9.38e-06	0.000107	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—MAPK3—breast cancer	9.37e-06	0.000107	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—MYC—breast cancer	9.12e-06	0.000104	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PIK3CG—breast cancer	8.69e-06	9.94e-05	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PIK3CB—breast cancer	8.66e-06	9.9e-05	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PTGS2—breast cancer	8.58e-06	9.81e-05	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—MAPK3—breast cancer	8.38e-06	9.58e-05	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—MYC—breast cancer	8.15e-06	9.32e-05	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PIK3CD—breast cancer	7.64e-06	8.74e-05	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ALB—breast cancer	7.55e-06	8.63e-05	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PTEN—breast cancer	7.48e-06	8.56e-05	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NOS3—breast cancer	7.22e-06	8.25e-05	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—TP53—breast cancer	6.69e-06	7.66e-05	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PIK3CB—breast cancer	6.66e-06	7.62e-05	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PTGS2—breast cancer	6.6e-06	7.55e-05	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PTEN—breast cancer	5.76e-06	6.58e-05	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PIK3CA—breast cancer	5.28e-06	6.04e-05	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—AKT1—breast cancer	4.31e-06	4.93e-05	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PIK3CA—breast cancer	4.06e-06	4.64e-05	CbGpPWpGaD
Fludarabine—DCK—Metabolism—AKT1—breast cancer	3.32e-06	3.79e-05	CbGpPWpGaD
